Tag: Big Pharma
Business & Industry
AstraZeneca CSPC Weight-Loss Deal Reaches $18.5 Billion
AstraZeneca has agreed to license experimental obesity and metabolic disease drugs from China’s CSPC Pharmaceutical Group under the AstraZeneca CSPC weight-loss deal, with total...
Business & Industry
Novartis, SciNeuro Brain Shuttle Deal Expands Neuroscience
Novartis has entered into a licensing agreement with SciNeuro Pharmaceuticals focused on improving drug delivery to the brain. The Novartis and SciNeuro brain shuttle...
News
Bayer-Attralus Diagnostic Tracers Deal Expands Imaging Reach
In order to broaden its portfolio in imaging and cardiovascular medicine, Bayer has agreed to purchase two experimental diagnostic imaging agents from Attralus. The...
Business & Industry
Revvity and Lilly Expand Lilly TuneLab Access via Signals
Revvity, Inc. announced a collaboration with Eli Lilly and Company to broaden access to Lilly TuneLab by bringing the platform to the Revvity Signals...
Clinical Trials
B-Well 1 And B-Well 2 Phase III Trials Fare Well from GSK
GSK plc has announced positive results coming from its two pivotal phase III trials - the B-Well 1 and B-Well 2 phase III trials,...
Business & Industry
InduPro, Lilly Partner to Discover Novel Cancer Treatments
Shortly after going ahead and securing a partnership with Sanofi, InduPro is now linking up with Eli Lilly in its endeavors to discover novel...
Business & Industry
Nimbus, Lilly Ink Licence Agreement on Treatments in Obesity
Nimbus Therapeutics has announced that it has entered into a multi-year research partnership and a $1.3 billion exclusive license agreement with Eli Lilly in...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read